HRT, Zyprexa , Lilly and the Death of Jack

by FRED GARDNER

Even though it made some front pages, the HRT KILLS story has been downplayed tremendously. Many more American civilians have been killed by Big Pharma’s conspiracy to peddle HRT drugs than by the attack on the World Trade Center. In the aftermath of Sept. 11, 2001, the media ran moving obituaries of the victims (never before or since have restaurant workers been shown such respect) and sought to explain, accurately or otherwise, the decision-making structure of Al Qaeda.

"BREAST CANCER RATE PLUMMETS" could have run in 80-point type above the banner, accompanied by an explanation of the findings, profiles of women who contracted breast cancer or suffered blood clots after taking estrogen and progestin pills, and an expose of the vast conspiracy to sell these drugs to treat "symptoms of menopause" (as if menopause was a disease).

The corporados know how to fan the flames of discontent and they know how to damp them down. HRT KILLS got a two-day follow-up in which apologists for the drug companies and the medical establishment tried to minimize the significance of the report by epidemiologists at M.D. Anderson Cancer Center in Houston showing that in 2003, as millions of middle-aged women stopped taking their HRT drugs, the incidence of estrogen-positive breast cancers (the most common type) dropped by 15%.

The New York Times ran this summary of the corporate line from Robert C. Wallach, MD, a professor of gynecology at the NYU Clinical Cancer Center:

"The decreased incidence of breast cancer may reflect better technology and increased discovery in prior years, lessening the number of cancers found later. Lowered incidence might reflect less screening. The study showing that hormones cause breast cancer, heart attacks, strokes and blood clots may be applicable only to the participants who were much older than the usual candidates for hormone use.

Breast cancer in hormone users has been reported to be less aggressive, possibly reflecting earlier discovery due to increase in size without increase in spread. The relation between hormones and breast cancer is more complex than you appreciate."

Apparently the smattering of Latin Dr. Wallach learned in med school did not include the phrase "mea culpa."

The conspiracy to sell HRT was vast, as befits one of the drug industry’sall-time blockbusters, and we can’t expect the corporate media to help bring its perpetrators to justice because the corporate media was part of the conspiracy. Here’s one small, finite example of the insidious campaign, from a column by Joan Ryan of Hearst’s San Francisco Examiner called "Lady Golfers Take A Swing At An Old Taboo." (It stuck it my craw because my father was the Ladies Professional Golf Association publicist in the Patty Berg-Louise Suggs era.) Ryan praised Eli Lilly, which was then pushing the HRT drug Evista, for sponsoring booths at LPGA tournaments where "women stop in to ask, quietly, about hot flashes, bloating, night sweats, mood swings, insomnia, hormone replacement therapy." Ryan quoted Betsy King, a 42-year-old golfer who won the Lilly Legend series in ’97: "This has been a great learning experience for me. I didn’t pay any attention to the issues the way I should have."

My wife commented, "Why should a 42-year-old woman be thinking about menopause? Hormone replacement therapy -that’s what’s really dangerous about menopause. Women used to stop having their periods and that was that. What’s different nowadays? If the symptoms are so much more severe, they ought to look for the causes. Couldn’t be all the pesticides we’ve been exposed to, could it?"

The executives of Eli Lilly go right on deploying their sales force, knowingly, to get doctors to prescribe drugs that disable and kill us. Last week Lilly was exposed orchestrating a sales push for Zyprexa as a treatment for dementia. Approved by the FDA as an anti-psychotic, Zyprexa causes enormous, unhealthy weight gain leading to diabetes, among other adverse effects. It brings in $4.2 billion for Lilly, whose execs were not only aware of the dangers in 1999, they created a task force to conceal and downplay them! At least 24 Lilly managers were informed of the existence of the duplicitous Zyprexa task force.

The Zyprexa story ran on the front pages within days of HRT KILLS but not presented as part of the same broader story, i.e., "The War on Us". The brief expose has an inoculating effect, like a minuscule dose of a pathogen administered so that the patient builds up antibodies and won’t succumb when exposed to lareer doses in the future. The longterm effect of muckraking can be protective for those exposed, creating an impression that the problem is now being solved. It takes SUSTAINED, purposeful coverage – the kind the corporate press has given the World Trade Center attack all these years- to generate public outrage and a political response. The Zyprexa story will now be shunted to the courts, where there are always two sides.

FRED GARDNER is a former Public Information Officer for the District Attorney of San Francisco. He can be reached at fred@plebesite.com

 

Like What You’ve Read? Support CounterPunch
August 31, 2015
Michael Hudson
Whitewashing the IMF’s Destructive Role in Greece
Conn Hallinan
Europe’s New Barbarians
Lawrence Ware
George Bush (Still) Doesn’t Care About Black People
Joseph Natoli
Plutocracy, Gentrification and Racial Violence
Franklin Spinney
One Presidential Debate You Won’t Hear: Why It is Time to Adopt a Sensible Grand Strategy
Dave Lindorff
What’s Wrong with Police in America
Louis Proyect
Jacobin and “The War on Syria”
Lawrence Wittner
Militarism Run Amok: How Russians and Americans are Preparing Their Children for War
Binoy Kampmark
Tales of Darkness: Europe’s Refugee Woes
Ralph Nader
Lo, the Poor Enlightened Billionaire!
Peter Koenig
Greece: a New Beginning? A New Hope?
Dean Baker
America Needs an “Idiot-Proof” Retirement System
Vijay Prashad
Why the Iran Deal is Essential
Tom Clifford
The Marco Polo Bridge Incident: a History That Continues to Resonate
Peter Belmont
The Salaita Affair: a Scandal That Never Should Have Happened
Weekend Edition
August 28-30, 2015
Randy Blazak
Donald Trump is the New Face of White Supremacy
Jeffrey St. Clair
Long Time Coming, Long Time Gone
Mike Whitney
Looting Made Easy: the $2 Trillion Buyback Binge
Alan Nasser
The Myth of the Middle Class: Have Most Americans Always Been Poor?
Rob Urie
Wall Street and the Cycle of Crises
Andrew Levine
Viva Trump?
Ismael Hossein-Zadeh
Behind the Congressional Disagreements Over the Iran Nuclear Deal
Lawrence Ware – Marcus T. McCullough
I Won’t Say Amen: Three Black Christian Clichés That Must Go
Evan Jones
Zionism in Britain: a Neglected Chronicle
John Wight
Learning About the Migration Crisis From Ancient Rome
Andre Vltchek
Lebanon – What if it Fell?
Charles Pierson
How the US and the WTO Crushed India’s Subsidies for Solar Energy
Robert Fantina
Hillary Clinton, Palestine and the Long View
Ben Burgis
Gore Vidal Was Right: What Best of Enemies Leaves Out
Suzanne Gordon
How Vets May Suffer From McCain’s Latest Captivity
Robert Sandels - Nelson P. Valdés
The Cuban Adjustment Act: the Other Immigration Mess
Uri Avnery
The Molten Three: Israel’s Aborted Strike on Iran
John Stanton
Israel’s JINSA Earns Return on Investment: 190 Americans Admirals and Generals Oppose Iran Deal
Bill Yousman
The Fire This Time: Ta-Nehisi Coates’s “Between the World and Me”
Scott Parkin
Katrina Plus Ten: Climate Justice in Action
Michael Welton
The Conversable World: Finding a Compass in Post-9/11 Times
Brian Cloughley
Don’t be Black in America
Kent Paterson
In Search of the Great New Mexico Chile Pepper in a Post-NAFTA Era
Binoy Kampmark
Live Death on Air: The Killings at WDBJ
Gui Rochat
The Guise of American Democracy
Emma Scully
Vultures Over Puerto Rico: the Financial Implications of Dependency
Chuck Churchill
Is “White Skin Privilege” the Key to Understanding Racism?
Kathleen Wallace
The Id(iots) Emerge
Andrew Stewart
Zionist Hip-Hop: a Critical Look at Matisyahu
Gregg Shotwell
The Fate of the UAW: Study, Aim, Fire